July 1, 2025 The natural history of biochemical recurrence (BCR) after radical prostatectomy (RP) remains understudied, with limited long-term data from large cohorts inclusive of both salvage ...

To close out Men’s Health Month, the Cancer Connections team sat down with Dr. William Dahut, the American Cancer Society’s ...

Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

Hormone therapy for prostate cancer is aimed at reducing or eliminating the amount of testosterone in your body to slow or stop prostate cancer cells from growing and multiplying. Hormone therapy ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically ...